Literature DB >> 26745666

Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.

Mary K Porteous1,2, Bonnie Ky1,2,3, James N Kirkpatrick4, Russell Shinohara2, Joshua M Diamond1,2, Rupal J Shah5, James C Lee1, Jason D Christie1,2, Steven M Kawut1,2,3.   

Abstract

RATIONALE: Primary graft dysfunction (PGD) is a significant cause of early morbidity and mortality after lung transplant and is characterized by severe hypoxemia and infiltrates in the allograft. The pathogenesis of PGD involves ischemia-reperfusion injury. However, subclinical increases in pulmonary venous pressure due to left ventricular diastolic dysfunction may contribute by exacerbating capillary leak.
OBJECTIVES: To determine whether a higher ratio of early mitral inflow velocity (E) to early diastolic mitral annular velocity (é), indicative of worse left ventricular diastolic function, is associated with a higher risk of PGD.
METHODS: We performed a retrospective cohort study of patients in the Lung Transplant Outcomes Group who underwent bilateral lung transplant at our institution between 2004 and 2014 for interstitial lung disease, chronic obstructive pulmonary disease, or pulmonary arterial hypertension. Transthoracic echocardiograms obtained during evaluation for transplant listing were analyzed for E/é and other measures of diastolic function. PGD was defined as PaO2/FiO2 less than or equal to 200 with allograft infiltrates at 48 or 72 hours after reperfusion. The association between E/é and PGD was assessed with multivariable logistic regression.
MEASUREMENTS AND MAIN RESULTS: After adjustment for recipient age, body mass index, mean pulmonary arterial pressure, and pretransplant diagnosis, higher E/é and E/é greater than 8 were associated with an increased risk of PGD (E/é odds ratio, 1.93; 95% confidence interval, 1.02-3.64; P = 0.04; E/é >8 odds ratio, 5.29; 95% confidence interval, 1.40-20.01; P = 0.01).
CONCLUSIONS: Differences in left ventricular diastolic function may contribute to the development of PGD. Future trials are needed to determine whether optimization of left ventricular diastolic function reduces the risk of PGD.

Entities:  

Keywords:  diastolic heart failure; left ventricular function; lung transplant; primary graft dysfunction; pulmonary hypertension

Mesh:

Year:  2016        PMID: 26745666      PMCID: PMC4910888          DOI: 10.1164/rccm.201508-1522OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  61 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

3.  Right-to-left ventricular diastolic delay in chronic thromboembolic pulmonary hypertension is associated with activation delay and action potential prolongation in right ventricle.

Authors:  Maxim Hardziyenka; Maria E Campian; Berto J Bouma; André C Linnenbank; H A C M Rianne de Bruin-Bon; Jaap J Kloek; Allard C van der Wal; Jan Baan; Edouard M de Beaumont; Herre J Reesink; Jacques M T de Bakker; Paul Bresser; Hanno L Tan
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-04

4.  Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.

Authors:  M N Samano; L M Fernandes; J C B Baranauskas; A T Correia; J E Afonso; R H O B Teixeira; M L Caramori; P M Pêgo-Fernandes; F B Jatene
Journal:  Transplant Proc       Date:  2012-10       Impact factor: 1.066

5.  Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation.

Authors:  Henrik Watz; Benjamin Waschki; Trhorsten Meyer; Gunther Kretschmar; Anne Kirsten; Martin Claussen; Helgo Magnussen
Journal:  Chest       Date:  2010-02-26       Impact factor: 9.410

6.  Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy.

Authors:  T Menzel; S Wagner; T Kramm; S Mohr-Kahaly; E Mayer; S Braeuninger; J Meyer
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

7.  Assessment of left ventricular diastolic function after single lung transplantation in patients with severe pulmonary hypertension.

Authors:  G Y Xie; C S Lin; H M Preston; C G Taylor; K Kearney; P M Sapin; M D Smith
Journal:  Chest       Date:  1998-08       Impact factor: 9.410

8.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

9.  Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure.

Authors:  Georg-Christian Funk; Irene Lang; Peter Schenk; Arschang Valipour; Sylvia Hartl; Otto Chris Burghuber
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

10.  Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] study.

Authors:  C E Papadopoulos; G Pitsiou; T D Karamitsos; H I Karvounis; T Kontakiotis; G Giannakoulas; G K Efthimiadis; P Argyropoulou; G E Parharidis; D Bouros
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

View more
  12 in total

1.  Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.

Authors:  Chad A Newton; Julia Kozlitina; Jefferson R Lines; Vaidehi Kaza; Fernando Torres; Christine Kim Garcia
Journal:  J Heart Lung Transplant       Date:  2017-02-04       Impact factor: 10.247

2.  Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Authors:  Mary K Porteous; James C Lee; David J Lederer; Scott M Palmer; Edward Cantu; Rupal J Shah; Scarlett L Bellamy; Vibha N Lama; Sangeeta M Bhorade; Maria M Crespo; John F McDyer; Keith M Wille; A Russell Localio; Jonathan B Orens; Pali D Shah; Ann B Weinacker; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie; Steven M Kawut; Joshua M Diamond
Journal:  Ann Am Thorac Soc       Date:  2017-10

Review 3.  Extracorporeal support, during and after lung transplantation: the history of an idea.

Authors:  Fabio Ius; Igor Tudorache; Gregor Warnecke
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.

Authors:  Daiga Saito; Rine Nakanishi; Ippei Watanabe; Takayuki Yabe; Ryo Okubo; Hideo Amano; Mikihito Toda; Takanori Ikeda
Journal:  Heart Vessels       Date:  2017-11-15       Impact factor: 2.037

5.  Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.

Authors:  Ciara M Shaver; Nancy Wickersham; J Brennan McNeil; Hiromasa Nagata; Adam Miller; Stuart R Landstreet; Jamie L Kuck; Joshua M Diamond; David J Lederer; Steven M Kawut; Scott M Palmer; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria M Crespo; Jonathan B Orens; Pali D Shah; Chadi A Hage; Edward Cantu; Mary K Porteous; Gundeep Dhillon; John McDyer; Julie A Bastarache; Jason D Christie; Lorraine B Ware
Journal:  JCI Insight       Date:  2018-01-25

Review 6.  Pathophysiology and classification of primary graft dysfunction after lung transplantation.

Authors:  Morvern Isabel Morrison; Thomas Leonard Pither; Andrew John Fisher
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

7.  Prognostic value of pre-transplant mean pulmonary arterial pressure in lung transplant recipients: a single-institution experience.

Authors:  Chi Young Kim; Ji Eun Park; Ah Young Leem; Joo Han Song; Song Yee Kim; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Joon Chang; Jin Gu Lee; Hyo Chae Paik; Moo Suk Park
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

8.  Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.

Authors:  Jake G Natalini; Joshua M Diamond; Mary K Porteous; David J Lederer; Keith M Wille; Ann B Weinacker; Jonathan B Orens; Pali D Shah; Vibha N Lama; John F McDyer; Laurie D Snyder; Chadi A Hage; Jonathan P Singer; Lorraine B Ware; Edward Cantu; Michelle Oyster; Laurel Kalman; Jason D Christie; Steven M Kawut; Elana J Bernstein
Journal:  J Heart Lung Transplant       Date:  2021-01-23       Impact factor: 10.247

Review 9.  Primary graft dysfunction: what we know.

Authors:  Emily Clausen; Edward Cantu
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

10.  Early Graft Dysfunction after Lung Transplantation.

Authors:  Justin Rosenheck; Colleen Pietras; Edward Cantu
Journal:  Curr Pulmonol Rep       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.